Vimarsana
Biggest News Aggregation in the World

Ichthyosis Severity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ichthyosis Severity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ichthyosis Severity Today - Breaking & Trending Today

Topical isotretinoin ointment shows 'reassuring' efficacy, safety in congenital ichthyosis - Vimarsana News

Topical isotretinoin ointment shows 'reassuring' efficacy, safety in congenital ichthyosis

Two formulations of a novel topical isotretinoin ointment formulation were associated with improvements over vehicle in patients with two types of congenital ichthyosis, according to a study.“Congenital ichthyosis (CI) is being studied because there are no FDA-approved treatments and there is a significant unmet clinical need for this lifetime challenging condition,” Joyce M. C. Teng,

Source: healio.com
Phase 3 Trial in Progress of New Ichthyosis Treatment - Vimarsana News

Phase 3 Trial in Progress of New Ichthyosis Treatment

Phase 3 Trial in Progress of New Ichthyosis Treatment

Yale tests a treatment for skin diseases that often target children - Vimarsana News

Yale tests a treatment for skin diseases that often target children

Yale dermatologists are playing a key role in testing a new treatment for an often-disfiguring group of skin diseases that develop in children.

Source: yale.edu
Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress - Vimarsana News

Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV Congress

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Source: apnews.com
Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study - Vimarsana News

Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study

- Company announces positive clinical data of FDA-Designated Breakthrough Therapy TMB-001 demonstrating safety, efficacy and quality of life improvements...